logo
15:51 May 29

Alembic Ltd.

Sector Pharmaceuticals & Biotechnology Industry Pharmaceuticals
Up
87.64
+0.51 (+0.59%)
Sector Pharmaceuticals & Biotechnology Industry Pharmaceuticals

Alembic Ltd. Financials

Alembic Ltd.
Sector Pharmaceuticals & Biotechnology
Industry Pharmaceuticals
Up
87.64
+0.51 (+0.59%)
15:51 May 29
Quality
image/svg+xml

66/100
High Financial Strength

Valuation
image/svg+xml

43/100
Mid Valuation

Technical

34/100
Technically Bearish

Strength

7

Weakness

5

Opportunity

0

Threats

0

12.98 %

ROE %

12.25 %

ROA %

12.36

EPS

95.22

BVPS

132.24 %

Net Profit Margin

Mar 2022 Mar 2023 Mar 2024 Mar 2025 Mar 2026
Net Sales
78.22 127.24 157.49 221.89 239.99
Operating Expenses +
64.29 86.91 100.62 128.18 149.53
Raw Material
8.53 6.92 8.62 8 13.88
Increase Decrease in Cost
2.46 -0.6 0.53 1.11 2.55
Other Manufacturing Expense
11.64 34.8 39.81 60.05 0
Employee Cost
21.47 24.04 23.03 27.31 37.44
Miscellaneous Expenses
20.19 21.75 28.63 31.71 95.66
Operating Profit
13.93 40.33 56.87 93.71 90.46
Other Income
89.18 64.26 54.77 74.89 72.97
Depreciation
4.86 6.72 7.84 10.63 12.39
Interest
0.39 0.47 1.11 2.47 2.28
Profit before tax and exceptio..
97.86 97.41 102.69 155.5 148.76
Exceptional Items
0 -10.61 0 0 0
PBT
97.86 86.8 102.69 155.5 148.76
Provision for Taxation
11.66 6.18 9.82 10.93 22.83
Net Profit
86.19 80.62 92.87 144.57 125.93
NET Profit after MI
222.06 190.65 268.62 310.68 317.38
EPS
8.65 7.42 10.46 12.1 12.36
Operating Profit Margin (%)
17.81 31.7 36.11 42.23 37.69
Net Profit Margin (%)
283.89 149.84 170.56 140.02 132.25

Alembic Ltd. Shareholding

All Data in Percentage (%)
Promoter - - - - -
FII - - - - -
Public - - - - -
MF - - - - -
Others
Shareholder Shares Holding %
Research 360 logo
Download Our App On: